TScan Therapeutics Inc. (TCRX)
2.65
0.02 (0.76%)
At close: Jan 15, 2025, 3:59 PM
2.65
0.00%
After-hours Jan 15, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -4.29 | -0.57 | -2.21 | -10.06 | -19.98 |
| PS Ratio | 18.17 | 2.75 | 10.61 | 241.34 | n/a |
| PB Ratio | 2.53 | 0.37 | 0.67 | -6.17 | -15.28 |
| P/FCF Ratio | -5.93 | -0.53 | -1.84 | -36.06 | -19.02 |
| P/OCF Ratio | -6.23 | -0.56 | -2.21 | -86.62 | -20.91 |
| OCF/S Ratio | -2.92 | -4.91 | -4.8 | -2.79 | n/a |
| Debt / Equity Ratio | 0.61 | 0.86 | 0.04 | -0.18 | -0.29 |
| Quick Ratio | 6.51 | 6.94 | 7.76 | 2.09 | 17.69 |
| Current Ratio | 6.51 | 6.94 | 7.76 | 2.09 | 17.69 |
| Asset Turnover | 0.08 | 0.07 | 0.05 | 0.02 | n/a |
| Interest Coverage | -24.86 | -56.66 | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.59 | -0.66 | -0.3 | 0.61 | 0.76 |
| Return on Assets (ROA) | -0.33 | -0.33 | -0.26 | -0.52 | -0.27 |
| Return on Capital (ROIC) | -0.39 | -0.37 | -0.29 | -0.81 | -0.3 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -318.8% | 62.05% | 67.18% | -1.80K% | n/a |
| Net Profit Margin | -423.86% | -486.19% | -479.49% | -2.40K% | n/a |
| Pretax Profit Margin | -423.86% | -489.26% | -479.49% | -2.41K% | n/a |
| Operating Profit Margin | -444% | -492.32% | -479.65% | -2.42K% | n/a |
| FCF Margin | -306.45% | -522.56% | -578.03% | -669.22% | n/a |
| EBITDA Margin | -380.53% | -442.62% | -446.67% | -2.30K% | n/a |